Shin Nippon Biomedical Laboratories (TSE:2395) Total Assets : 円71,372 Mil (As of Dec. 2023)

Shin Nippon Biomedical Laboratories Total Assets Chart

Shin Nippon Biomedical Laboratories Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Total Assets		Get a 7-Day Free Trial					39,002.29	36,972.40	39,312.66	57,242.21	76,302.35

Shin Nippon Biomedical Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															57,242.21	62,615.17	68,558.34	71,371.71	76,302.35

Shin Nippon Biomedical Laboratories Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shin Nippon Biomedical Laboratories's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Shin Nippon Biomedical Laboratories's Total Assets for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories  (TSE:2395) Total Assets Explanation

Total Assets is connected with ROA %.

Shin Nippon Biomedical Laboratories's annualized ROA % for the quarter that ended in Dec. 2023 is

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shin Nippon Biomedical Laboratories's Asset Turnover for the quarter that ended in Dec. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shin Nippon Biomedical Laboratories Total Assets Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shin Nippon Biomedical Laboratories (TSE:2395) Business Description